Page last updated: 2024-10-22

aminoglutethimide and Hyperlipidemias

aminoglutethimide has been researched along with Hyperlipidemias in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Hyperlipidemias: Conditions with excess LIPIDS in the blood.

Research Excerpts

ExcerptRelevanceReference
"Plasma levels of cholesterol, HDL cholesterol (HDL chol), LDL cholesterol (LDL chol), triglycerides, Al apoprotein and B apoprotein were studied in 73 patients receiving 500 mg aminoglutethimide (AG)/day and 40 mg hydrocortisone/day for advanced breast cancer."3.67[Aminoglutethimide-induced dyslipemia. Clinical study]. ( Bonneterre, J; Demaille, A; Fournier, C; Hecquet, B; Nguyen, M, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonneterre, J1
Nguyen, M1
Hecquet, B1
Fournier, C1
Demaille, A1

Other Studies

1 other study available for aminoglutethimide and Hyperlipidemias

ArticleYear
[Aminoglutethimide-induced dyslipemia. Clinical study].
    Bulletin du cancer, 1985, Volume: 72, Issue:2

    Topics: Aminoglutethimide; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Breast Neoplasms; Chole

1985